The Quantellect read.As of Nov 19, 2026, 5 active firms cover Evolus Inc: 4 rate it Buy or better, 1 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $13.00 to $19.00, a moderate spread. The average target of $15.50 sits 119% above the current $7.07. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.00 next quarter toward $0.29 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 active firms
Buy
Strong Buy00%
Buy480%
Neutral120%
Sell00%
Strong Sell00%
Based on 5 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$15.50
+119.4% upside
Average target across 4 active firms as of Nov 19, 2026 vs $7.07 current
Highest Target$19.00
Average Target$15.50
Lowest Target$13.00
Detailed analyst forecasts for EOLS
Showing 1–5 of 5 named analysts shown · 5 active firms in the rating projection
As of Nov 19, 2026, 4 of 5 active firms rate EOLS a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
EOLS EPS & revenue forecast
EPS · NEXT QUARTER
$0.00
Range $0.00 – $0.00 · 1 analysts · -100% YoY
Next period, 1 analysts expect Evolus Inc to earn $0.00 a share (range $0.00 – $0.00), versus $-0.05 a year earlier. Full-year consensus is $-0.03, growing to $0.29 the year after.
REVENUE · NEXT QUARTER
$87.9M
Range $83.8M – $92.0M · 1 analysts · +20% YoY
Revenue is expected to reach $87.9M (range $83.8M – $92.0M), +20.2% year-over-year. Full-year consensus is $334.3M, rising to $390.6M next year.
Top analysts covering Evolus Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EOLS.
#1
Serge Belanger
Needham · Rank #129
Neutral
No targeton EOLS
Overall win rate
46%
+ Follow
#2
Balaji Prasad
Barclays · Rank #226
Buy
$25.00+253.9% to target
Overall win rate
45%
+ Follow
#3
Marc Goodman
Leerink Partners · Rank #251
Buy
No targeton EOLS
Overall win rate
46%
+ Follow
#4
Douglas Tsao
HC Wainwright & Co. · Rank #312
Buy
$13.00+84.0% to target
Overall win rate
35%
+ Follow
#5
SE
Sam Eiber
BTIG
Buy
$13.00+84.0% to target
Coverage
—
+ Follow
EOLS stock forecast FAQ
What is EOLS's average 12-month price target?+
The 4 active firms with a live target average $15.50 for Evolus Inc over the next 12 months, ranging from a $19.00 high to a $13.00 low, as of Nov 19, 2026.
Is EOLS stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 5 active firms as of Nov 19, 2026, 4 rate it Buy or Strong Buy, 1 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for EOLS?+
The Street-high target is $19.00 (Mizuho), and the Street-low is $13.00 (HC Wainwright & Co.). The average of all 4 active-firm targets is $15.50.
How many active Wall Street firms cover EOLS?+
5 active firms have a recognized rating on Evolus Inc as of Nov 19, 2026, and 4 active firms carry a live 12-month price target.
Who is the most accurate analyst covering EOLS?+
Among analysts who currently cover EOLS, Serge Belanger of Needham has the strongest overall Quantellect track record (Rank #129). Their current call is Neutral.
What is Evolus Inc's projected EPS for next quarter?+
The consensus estimate is $0.00 per share (range $0.00 – $0.00) across 1 analysts. Full-year EPS is projected at $-0.03, rising to $0.29 the following year.
How much revenue is Evolus Inc expected to report next quarter?+
Consensus revenue is $87.9M (range $83.8M – $92.0M). Full-year revenue is projected at $334.3M, growing to $390.6M next year.
Have analysts been upgrading or downgrading EOLS lately?+
As of Nov 19, 2026, 4 of 5 active firms rate EOLS a Buy (1 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EOLS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.